Cell and gene therapies could be a safer bet than other drugs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, everyone. Damian here with data on biotech’s belt-tightening, the advance of xenotransplantation, and the escalating Ozempic panic.
Read Original Article: Cell and gene therapies could be a safer bet than other drugs »
